NeuroVive Pharmaceutical AB

ISIN SE0011089002Filings at the FI

At a glance

Most recent filing on April 25, 2018 — a grant by Magnus Hansson on Apr 24, 2018.

We hold 1 visible filing, going back to April 24, 2018.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

All 1 shown

  • Magnus Hansson Chief medical officer
    160,000 SEKGrant
    TradedApr 24, 2018FiledApr 25, 2018